159 related articles for article (PubMed ID: 22010535)
1. The dangerous synergism between influenza and Streptococcus pneumoniae and innovative perspectives of vaccine prevention.
Alicino C; Iudici R; Alberti M; Durando P
J Prev Med Hyg; 2011 Sep; 52(3):102-6. PubMed ID: 22010535
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal pneumonia and influenza: a deadly combination.
Klugman KP; Chien YW; Madhi SA
Vaccine; 2009 Aug; 27 Suppl 3():C9-C14. PubMed ID: 19683658
[TBL] [Abstract][Full Text] [Related]
3. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor.
McCullers JA; Rehg JE
J Infect Dis; 2002 Aug; 186(3):341-50. PubMed ID: 12134230
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
[TBL] [Abstract][Full Text] [Related]
5. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?
Short KR; Habets MN; Hermans PW; Diavatopoulos DA
Future Microbiol; 2012 May; 7(5):609-24. PubMed ID: 22568716
[TBL] [Abstract][Full Text] [Related]
6. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
[TBL] [Abstract][Full Text] [Related]
7. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
[TBL] [Abstract][Full Text] [Related]
8. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
[TBL] [Abstract][Full Text] [Related]
9. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ; McIntosh ED; Reinert RR
Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
[TBL] [Abstract][Full Text] [Related]
10. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
11. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
12. Global prevailing and emerging pediatric pneumococcal serotypes.
McIntosh ED; Reinert RR
Expert Rev Vaccines; 2011 Jan; 10(1):109-29. PubMed ID: 21162625
[TBL] [Abstract][Full Text] [Related]
13. Preventing pneumonia: the role for pneumococcal and influenza vaccines.
Shorr AF
Clin Chest Med; 2005 Mar; 26(1):123-34. PubMed ID: 15802174
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of pneumonia with Streptococcus pneumoniae infection by inoculation with a vaccine against highly pathogenic avian influenza virus in a non-human primate mixed infection model.
Miyake T; Soda K; Itoh Y; Sakoda Y; Ishigaki H; Nagata T; Ishida H; Nakayama M; Ozaki H; Tsuchiya H; Torii R; Kida H; Ogasawara K
J Med Primatol; 2010 Feb; 39(1):58-70. PubMed ID: 19900170
[TBL] [Abstract][Full Text] [Related]
15. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC; Baughman W; Schmotzer B; Farley MM
Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
[TBL] [Abstract][Full Text] [Related]
16. Effective protection against secondary pneumococcal pneumonia by oral vaccination with attenuated Salmonella delivering PspA antigen in mice.
Seo SU; Kim JJ; Yang H; Kwon HJ; Yang JY; Curtiss Iii R; Kweon MN
Vaccine; 2012 Nov; 30(48):6816-23. PubMed ID: 23000127
[TBL] [Abstract][Full Text] [Related]
17. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
[No Abstract] [Full Text] [Related]
18. [Prevention of community-acquired pneumonia in adults].
Barros M M; Cartagena S C; Bavestrello F L
Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421
[TBL] [Abstract][Full Text] [Related]
19. The safety of 7-valent pneumococcal conjugate vaccine.
Ghaffar F
Expert Opin Drug Saf; 2005 Jul; 4(4):631-6. PubMed ID: 16011442
[TBL] [Abstract][Full Text] [Related]
20. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
